A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice

Microbes and Infection

Volumn 9, Issue 14-15, 2007, Pages 1614-1622

  Beauvillain, Céline ^a,b   Ruiz, Sophie ^a   Guiton, Rachel ^a   Bout, Daniel ^a   Dimier Poisson, Isabelle ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Dendritic cells; Exosomes; Toxoplasma gondii; Vaccine

Indexed keywords

CYTOKINE; EXOSOME PROTEIN; IMMUNOGLOBULIN A ANTIBODY; NUCLEIC ACID; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CBA MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE MODEL; EXOSOME; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SPLEEN; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL LINE; CYTOPLASMIC VESICLES; DENDRITIC CELLS; EXOCYTOSIS; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

MUS; TOXOPLASMA GONDII;

EID: 36849042099     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.07.002     Document Type: Article

References (29)

1. Denkers E.Y., Butcher B.A., Del Rio L., and Bennouna S. Neutrophils, dendritic cells and Toxoplasma. Int. J. Parasitol 34 (2004) 411-421
2. Buxton D., and Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 110 Suppl. (1995) S11-S16
3. Bonenfant C., Dimier-Poisson I., Velge-Roussel F., Buzoni-Gatel D., Del Giudice G., Rappuoli R., and Bout D. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect. Immun. 69 (2001) 1605-1612
4. Banchereau J., and Palucka K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5 (2005) 296-306
5. Conrad C., and Nestle F.O. Dendritic cell-based cancer therapy. Curr. Opin. Mol. Ther. 5 (2003) 405-412
6. Bourguin I., Moser M., Buzoni-Gatel D., Tielemans F., Bout D., Urbain J., and Leo O. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 66 (1998) 4867-4874
7. Iwasaki A., and Kelsall B.L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190 (1999) 229-239
8. Thery C., Zitvogel L., and Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2 (2002) 569-579
9. Wolfers J., Lozier A., Raposo G., Regnault A., Thery C., Masurier C., Flament C., Pouzieux S., Faure F., Tursz T., Angevin E., Amigorena S., and Zitvogel L. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7 (2001) 297-303
10. van Niel G., Raposo G., Candalh C., Boussac M., Hershberg R., Cerf-Bensussan N., and Heyman M. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121 (2001) 337-349
11. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., Ricciardi-Castagnoli P., Raposo G., and Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4 (1998) 594-600
12. Chaput N., Taieb J., Schartz N., Flament C., Novault S., Andre F., and Zitvogel L. The potential of exosomes in immunotherapy of cancer. Blood Cells Mol. Dis. 35 (2005) 111-115
13. Ruiz S., Beauvillain C., Mevelec M.-N., Roingeard P., Breton P., Bout D., and Dimier-Poisson I. A novel CD4 - CD8alpha + CD205 + CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis. Cell. Microbiol. 7 (2005) 1659-1671
14. Chardes T., Bourguin I., Mevelec M.-N., Dubremetz J.-F., and Bout D. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect. Immun. 58 (1990) 1240-1246
15. Bout D., Moretto M., Dimier-Poisson I., and Buzoni-Gatel D. Interaction between Toxoplasma gondii and enterocyte. Immunobiology 201 (1999) 225-228
16. Dimier-Poisson I., Aline F., Mevelec M.-N., Beauvillain C., Buzoni-Gatel D., and Bout D. Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells. Infect. Immun. 71 (2003) 5254-5265
17. Fevrier B., and Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16 (2004) 415-421
18. Aline F., Bout D., Amigorena S., Roingeard P., and Dimier-Poisson I. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect. Immun. 72 (2004) 4127-4137
19. Kang H., Remington J.S., and Suzuki Y. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J. Immunol. 164 (2000) 2629-2634
20. Sayles P.C., Gibson G.W., and Johnson L.L. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect. Immun. 68 (2000) 1026-1033
21. Gazzinelli R.T., Denkers E.Y., and Sher A. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect. Agents Dis. 2 (1993) 139-149
22. Johnson L.L., and Sayles P.C. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice. Infect. Immun. 70 (2002) 185-191
23. Liesenfeld O., Kosek J., Remington, and Suzuki Y. Association of CD4 + T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184 (1996) 597-607
24. Andre F., Chaput N., Schartz N.E., Flament C., Aubert N., Bernard J., Lemonnier F., Raposo G., Escudier B., Hsu D.H., Tursz T., Amigorena S., Angevin E., and Zitvogel L. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 172 (2004) 2126-2136
25. Thery C., Duban L., Segura E., Veron P., Lantz O., and Amigorena S. Indirect activation of naive CD4 + T cells by dendritic cell-derived exosomes. Nat. Immunol. 3 (2002) 1156-1162
26. Hwang I., Shen X., and Sprent J. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc. Natl. Acad. Sci. USA 100 (2003) 6670-6675
27. Chaput N., Schartz N.E., Andre F., Taieb J., Novault S., Bonnaventure P., Aubert N., Bernard J., Lemonnier F., Merad M., Adema G., Adams M., Ferrantini M., Carpentier A.F., Escudier B., Tursz T., Angevin E., and Zitvogel L. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J. Immunol 172 (2004) 2137-2146
28. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., and Murphy K.M. Development of TH1 CD4 + T cells through IL-12 produced by Listeria-induced macrophages. Science 260 (1993) 547-549
29. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., and Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J. Biol. Chem. 273 (1998) 20121-20127